期刊
JOURNAL OF BIOCHEMISTRY
卷 160, 期 3, 页码 121-129出版社
OXFORD UNIV PRESS
DOI: 10.1093/jb/mvw044
关键词
iPS cell; reprogramming; pluripotency; differentiation; safety
资金
- JSPS KAKENHI Grant [26461004, 26293317]
- Grants-in-Aid for Scientific Research [26461004, 26293317] Funding Source: KAKEN
In 2006, induced pluripotent stem (iPS) cells were generated by Yamanaka and Takahashi for the first time from a mouse fibroblast culture by introducing four factors. In the 10 years since then, this breakthrough discovery has been making waves in the fields of biology and medical science. For example, various technologies for generating iPS cells have been developed, and we have cultivated a better understanding of the mechanisms involved in reprogramming. In addition, many researchers have explored the applications of iPS cells, such as drug discovery, the study of disease mechanisms and regenerative medicine, and the development of advanced technologies for the differentiation and qualification of the cells. Furthermore, the concept of iPS cell generation has inspired a number of studies that do not use iPS cells. We herein review and discuss the past, present and future of iPS cells and their related issues.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据